© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#leukemia
How Does Leukemia Escape From Immunotherapy?
How AI Found the Words to Kill Cancer Cells
Leukemia 101
Cayden at 6 years old. He was diagnosed with leukemia and later had CAR-T therapy

Dare to Dream a Better Future for Children With Blood Cancers

The Leukemia & Lymphoma Society’s Dare to Dream project helps pediatric cancer patients like Cayden, who received CAR-T therapy.
E. Anders Kolb, MD, is president and CEO of the Leukemia and Lymphoma Society

My First 100 Days as President & CEO of The Leukemia & Lymphoma Society

“I envision LLS continuing to be a leading innovator, driving change that impacts all cancer care,” says E. Anders Kolb, MD.

Count on the Leukemia & Lymphoma Society This Blood Cancer Awareness Month

That’s a new blood cancer diagnosis approximately every three minutes.

Chemo Drug Shortage

The drug shortage has impacted 93% of surveyed cancer centers, according to the National Comprehensive Cancer Network.

A New Treatment Option for Acute Myeloid Leukemia, Including in Older Patients

The FDA approved Vanflyta (quizartinib) with chemotherapy for FLT3-mutated AML, an aggressive type of blood cancer.

Microbiome Before a Bone Marrow Transplant Sets the Stage for GVHD

Preclinical findings highlight bacterial groups that influence the risk for graft-versus-host-disease in blood cancer transplant patients.

White House Announces First 10 Drugs Selected for Medicare Price Negotiation

The days of Americans paying far more for prescription drugs are ending, said President Biden.

Cancer Health 25: Champions of Health Equity

These individuals work to ensure fair opportunities to prevent, treat and survive cancer.

Breaking Down Barriers in Blood Cancer Care

Meet the latest grant recipients of The Leukemia & Lymphoma Society’s Equity in Access Research Program.
Cancer treatment

Preventing Graft-Versus-Host Disease After a Stem Cell Transplant

A three-drug regimen helps protect against GVHD after stem cell transplant for those with leukemia, lymphoma and similar cancers.

Obesity and High Weight Linked to Adverse Outcomes in Leukemia Treatment

New research by Dana-Farber scientists looks at elevated body mass index and chemotherapy for acute lymphoblastic leukemia (ALL).

Hot topics

Chronic Lymphocytic Leukemia
Acute Lymphocytic Leukemia

FDA Approves Vanflyta for Newly Diagnosed Acute Myeloid Leukemia

Trial showed that treatment with quizartinib led to a significant improvement in overall survival.
Pioneering breast cancer surgeon and activist Susan Love, MD

Susan Love, MD, Breast Cancer Surgeon and Advocate, Dies at 75

An influential author and out lesbian, Susan Love advanced innovative ideas on breast cancer as well as hormone replacement therapy.
Past LLS president and CEO Louis J. DeGennaro, PhD

A Farewell Message From The Leukemia & Lymphoma Society’s Retiring Leader

Loui J. DeGennaro, PhD, served 18 years at LLS, a nonprofit funder of blood cancer research and clinical trials.

100 Blood Cancer Advocates Visit Washington, Urge Lawmakers to Act

Lawmakers were asked to support the NIH Clinical Trials Diversity Act and kids’ access to cancer care.
Charlie Huang

Finding the Right Match: Leukemia, a Stem Cell Donor and Charlie’s Law

When Charlie Huang almost lost the chance at a lifesaving stem cell transplant for his acute myeloid leukemia, he vowed to help others.
Advertisement

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.